Processa Pharmaceuticals Announces First Patient Enrolled in the PCS12852 Phase 2A Trial for … – KULR-TV April 5, 2022 by Bette L.Processa Pharmaceuticals Announces First Patient Enrolled in the PCS12852 Phase 2A Trial for … KULR-TVsource